Skip to content New The AI buying guide for BD&L executives — now available on demand Watch
News

STAT – Upending drug industry financing

Pills on a red background beside a hundred-dollar bill

Allison DeAngelis authored this article, featuring Vibe Bio CEO, Alok Tayi, on ‘decentralized science’ which seeks to upend drug industry financing. The article detailed Alok’s journey to founding Vibe Bio.

“The experience stuck with Tayi, who is a scientist and entrepreneur, and led him to co-found a new organization that’s designed to allow patients, scientists, and other experts to have a say in financing rare disease drug development. The organization, Vibe Bio, launched on Wednesday with $12 million in seed funding.”

Read more…

Co-founder and CEO

Alok has 15 years of experience as a scientist and 12 as a serial entrepreneur. After completing postdoctoral work at Harvard University with George Whitesides, Alok started two pharma SaaS companies, PreScouter and TetraScience, which employ several hundred people combined…